Navigation Links
Luminex Corporation To Present At Leerink Swann Global Healthcare Conference
Date:1/31/2013

AUSTIN, Texas, Jan. 31, 2013 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the Leerink Swann Global Healthcare Conference to be held February 13 -14, 2013, in New York, NY.

(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

The investor presentation by Patrick J. Balthrop , president and chief executive officer, will begin at 11:30 a.m. Eastern time on Thursday, February 14, 2013.  The presentation will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com.  Simply log on to the web at the address above, go to the Company section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the 'replay' link.

ABOUT LUMINEX CORPORATION Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP® open-architecture, multi-analyte platform and MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic,
'/>"/>

SOURCE Luminex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Luminex Corporation Reports Third Quarter 2012 Results
2. Luminex Corporation To Present At Upcoming Investment Conferences In September
3. Luminex Corporation Hosts 10th Annual Planet xMAP Symposium in Monaco
4. Luminex Corporation Recognized as Best Technology Company in Austin
5. Luminex Corporation Awarded $11 Million Contract by Defense Threat Reduction Agency (DTRA)
6. Luminex Corporation and University Hospital of Wales Collaborate During Olympic Games
7. Luminex Corporation Reports Second Quarter 2012 Results
8. Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012
9. Luminex Corporation Announces Agreement to Acquire GenturaDx
10. Luminex Corporation Reports First Quarter 2012 Results
11. NewLink Genetics Corporation Announces Pricing of Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014  eRelevance Corporation ( www.erelevancecorp.com ), ... that it has completed integration with Nextech, a ... Surgery and Dermatology practices. "Integration allows ... healthcare practices using Nextech," stated Bob Fabbio ... information from the EMR we are able to ...
(Date:8/21/2014)... Aug. 21, 2014  Decision Resources Group finds ... Brazil and ... and commonly prescribe long-acting beta-agonist (LABA)- and long-acting ... so within current severe cost/coverage constraints. Therefore, new ... expected to launch in these countries—which will considerably ...
(Date:8/21/2014)... announces the list of stocks featured in the Analyst Blog. ... news and events impacting stocks and the financial markets. Stocks ... - Free Report ), IBM (NYSE: IBM - Free ... Report ), GlaxoSmithKline plc (NYSE: GSK - Free Report ... Report ). Today, Zacks is promoting its ,Buy, ...
Breaking Medicine Technology:eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 4The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 5The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 6The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 7The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 8The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 9The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 10The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 11
... , LAKE FOREST, Ill., Dec. 23 ... specialty pharmaceutical and medication delivery company, today announced that the ... Conference on Wednesday, Jan. 13, 2010, in San Francisco. , ... time on Wednesday, Jan. 13, 2010. It will be ...
... ... was marked by an abundance of media coverage and attention ... Hollywood. Over the past 12 months, several high-profile celebrities ... Lohan and, Courtney Love, while autopsies for Michael Jackson, Anna ...
Cached Medicine Technology:The Waismann Method Reflects on 2009: The Year of the Prescription Painkiller 2The Waismann Method Reflects on 2009: The Year of the Prescription Painkiller 3The Waismann Method Reflects on 2009: The Year of the Prescription Painkiller 4
(Date:8/22/2014)... autoimmune disease that affects 1 to 2 percent ... with pain, disability and joint disfigurements, but also ... and marital functioning. While many pharmacological advances help ... common. In addition, some patients avoid newer medications ... Because of this, there is interest in psychosocial ...
(Date:8/22/2014)... NV (PRWEB) August 22, 2014 ... Dr. Sen and Dr. Samantha Pearson to help people ... and avoid corrective vision surgery by instead improving their ... prompting an investigative review. , “There’s a reason ... dollars in revenue each year—it’s because people just assume ...
(Date:8/22/2014)... 2014 Testosterone treatment lawsuits ( ... courts on behalf of men who allegedly suffered ... prescription low testosterone therapies, Bernstein Liebhard LLP reports. ... filed against Pfizer Inc. on July 31st by ... issues due to his use of Depo-Testosterone. (Case ...
(Date:8/22/2014)... 22, 2014 Mueller Sports Medicine is ... an exciting new product that provides non-drug instant relief ... active while you heal. The package includes 7 days ... new technology – it is not kinesiology tape. It’s ... PFTape™ System for Plantar Fasciitis is a breakthrough ...
(Date:8/22/2014)... 22, 2014 The improved access to ... in the developing world, has led to the decline ... of deaths due to AIDS globally. However, despite the ... of new patients becoming affected by the virus is ... undertaken by all related organisations and stakeholders, by 2015, ...
Breaking Medicine News(10 mins):Health News:Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis 2Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Mueller Introduces FasciaDerm® PFTape™ System for Plantar Fasciitis 2Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 2Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 3
... stop trial-and-error warfarin dosing , FRIDAY, Sept. 7 (HealthDay ... anti-clotting drug warfarin should make it easier to prescribe ... , Up to this point, doctors have had to ... left patients at risk of hemorrhaging from low doses ...
... Ability to Improve Patient Care, LYNWOOD, Calif., ... Center have reached a tentative agreement on a ... increase their ability to,advocate for improved patient care, ... qualified and skilled staff. The agreement, which ...
... Concentra ("Concentra" or the,"Company"), a leader in on-site ... at the construction site of the former World,Trade ... workers a,convenient way to treat work related injuries. ... site treat construction,personnel, building partners, and other individuals ...
... AdvaMed General Counsel,Christopher White issued the following statement ... Patent Reform Act of 2007:, "The closely ... the significant bipartisan opposition to the patent reform,plan ... by,making patents easier to challenge and cheaper to ...
... Zimmer,Holdings, Inc. (NYSE: ZMH ; SWX: ZMH), ... (TSX-Venture: OSH), a leader in computer,navigation for orthopaedic ... Acquisition Co., has mailed today its offer and,circular ... takeover bid for all of ORTHOsoft,s outstanding common ...
... 650,000 hospital visits, U.S. study finds , FRIDAY, Sept. 7 (HealthDay ... both the little one and his or her family from getting ... U.S. children between six months and five years old got their ... visits due to flu could be prevented. , "We found that ...
Cached Medicine News:Health News:Researchers Find Better Way to Deliver Blood Thinner 2Health News:Workers Win Contract at St. Francis Medical Center 2Health News:Concentra Opens On-Site Medical Unit at World Trade Center Site 2Health News:Zimmer Holdings Offer and ORTHOsoft Directors' Circular Mailed to Shareholders 2Health News:Zimmer Holdings Offer and ORTHOsoft Directors' Circular Mailed to Shareholders 3Health News:Zimmer Holdings Offer and ORTHOsoft Directors' Circular Mailed to Shareholders 4Health News:Child's Flu Shot Helps Whole Family 2
Transcranial Doppler dedicated to intensive care unit and operating theatre....
The Spencer Technologies PMD 100 (TCD 100M) is the worlds first stand-alone digital transcranial doppler system....
Flagship Transcranial Doppler system with multiple channel options, multi-depth options....
The portable, cost-effective system designed for fast studies and bedside reporting. The size, features and cost make this a perfect unit for a new practice, or as a second or third unit for larger h...
Medicine Products: